On Sep 14, 2021 AgBiome closed a Series D round and raised $116,000,000 from Blue Horizon, Novalis LifeSciences, featuring lead investors Blue Horizon, Novalis LifeSciences. […]
Post-IPO Equity – Avalo Therapeutics
On Sep 14, 2021 Avalo Therapeutics closed a Post-IPO Equity round and raised $27,500,000 from investors, featuring lead investors . About the company: Avalo Therapeutics […]
Post-IPO Equity – Virpax Pharmaceuticals
On Sep 14, 2021 Virpax Pharmaceuticals closed a Post-IPO Equity round and raised $40,000,000 from investors, featuring lead investors . About the company: Virpax Pharmaceuticals […]
Post-IPO Equity – Virpax Pharmaceuticals
On Sep 14, 2021 Virpax Pharmaceuticals closed a Post-IPO Equity round and raised $40,000,000 from investors, featuring lead investors . About the company: Virpax Pharmaceuticals […]
BayMedica acquired by InMed Pharmaceuticals
Sep 13, 2021 InMed Pharmaceuticals has entered into an agreement to acquire BayMedica . InMed Pharmaceuticals based at Vancouver, British Columbia, Canada. “InMed is developing […]
First Wave Bio acquired by AzurRx BioPharma
Sep 13, 2021 AzurRx BioPharma has entered into an agreement to acquire First Wave Bio in a $229,000,000 deal. AzurRx BioPharma based at Brooklyn, New […]
Pre Seed Round – MeliBio
On Sep 13, 2021 MeliBio closed a Pre-Seed round and raised $250,000 from Cult Food Science, Kingfisher Capital LLC, featuring lead investors Cult Food Science. […]
Series B – TreeFrog Therapeutics
On Sep 13, 2021 TreeFrog Therapeutics closed a Series B round and raised €64,000,000 from Bpifrance, Bristol Myers Squibb, Leonard Green & Partners, XAnge, featuring […]
Series A – Walking Fish Therapeutics
On Sep 13, 2021 Walking Fish Therapeutics closed a Series A round and raised $50,000,000 from Emerson Collective, Illumina Ventures, Quan Capital, featuring lead investors […]
Series A – Formo
On Sep 13, 2021 Formo closed a Series A round and raised €42,000,000 from Agronomics, Albert Wenger, CPT Capital, Elevat3 Capital, EQT Ventures, Good Seed […]
